HIV-1 LTR-specific recombinase (Heinrich-Pette-Institut/Ascenion)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHIV-1 LTR-specific recombinase (Heinrich-Pette-Institut/Ascenion)
Drug Alias NameTre-recombinase (Heinrich-Pette-Institut/Ascenion)
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionEnzymes modulators
TargetsEnzymes
Therapy Area/IndicationsAcquired Immunodeficiency Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeibniz-Institut Für Wissensmedien
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeibniz-Institut Für WissensmedienAscenion
Active IndicationsN/A
Inactive IndicationsAcquired Immunodeficiency Syndrome

Other Information

ATC CodeN/A
Related LinksN/A